Form Type: 4

SEC EDGAR Link
Accession Number:0001601485-21-000058
Date:2021-09-20
Issuer: ANGION BIOMEDICA CORP. (ANGN)
Original Submission Date:

Reporting Person:

NEYLAN JOHN F.
C/O ANGION BIOMEDICA CORP.
51 CHARLES LINDBERGH BLVD. UNIONDALE, NY 11553

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-20 S 376 d $10.07 36,241 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the shares reported in this form 4 were sold pursuant to a 10b5-1 trading plan adopted by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock awards ("rsas") granted by the issuer.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $10.07 to $10.09 inclusive.
WhaleWisdom Logo

Elevate your investments